Skip to content

Clinical trials

Phase 2 Chronic Urticaria trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Chronic Urticaria Phase: Phase 2 Country / region: Germany Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20121
20151
20161
20183
20192
20201
20212
20222
20232
20241
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated7
Recruiting3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Allakos Inc.2
ARS Pharmaceuticals, Inc.1
Amgen1
AstraZeneca1
Blueprint Medicines Corporation1
Celldex Therapeutics1
Charite University, Berlin, Germany1
Eli Lilly and Company1
Escient Pharmaceuticals, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Chronic Urticaria23
Urticaria9
Pruritus5
Angioedema2
Bronchiolitis Obliterans Syndrome2
Chronic Inducible Urticaria2
Cold Urticaria2
Hidradenitis1
Hidradenitis Suppurativa1
Urticaria, Solar1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.